CoTherix Acquires Schering's U.S. Rights For Ventavis, Raises $55M Oct. 15, 2003 By Karen Carey The company formerly known as Exhale Therapeutics Inc. has acquired a new name, a new financing and new U.S. rights to a pulmonary hypertension product. (BioWorld Today)Read More
